Back to top
more

Clorox (CLX)

(Delayed Data from NYSE)

$162.77 USD

162.77
994,723

+0.07 (0.04%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 15% (37 out of 251)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Rajani Lohia headshot

5 Soaps & Cleaning Materials Stocks to Watch as Industry Catches Pace

by Rajani Lohia

The soap and cleaning materials industry looks poised for growth on robust demand, pricing initiatives, innovation, digital transformation and brand building, while elevated costs remain headwinds. Players like PG, CL, HENKY, CHD and CLX seem well-poised.

The Zacks Analyst Blog Highlights Cardinal Health, The Coca-Cola, General Mills, The Clorox and Cincinnati Financial

by Zacks Equity Research

Cardinal Health, The Coca-Cola, General Mills, The Clorox and Cincinnati Financial are part of the Zacks top Analyst Blog.

Here's Why Clorox (CLX) is Marching Ahead of Its Industry

by Zacks Equity Research

Despite inflation concerns, Clorox (CLX) looks well poised to drive growth in the future on the back of solid demand, pricing actions, cost savings efforts and other growth strategies.

Nalak Das headshot

5 Safe Stocks to Buy as SVB Collapse Shakes Wall Street

by Nalak Das

At this stage, it will be prudent to stay with safe stocks.Five such stocks are: CAH, CINF, CLX, KO and GIS.

Nalak Das headshot

5 Consumer Staples Stocks to Buy as Volatility Grips Markets

by Nalak Das

We have narrowed our search to five consumer staples stocks with strong potential for 2023. These are: CLX, GIS, KO, HSY and CHWY.

Tirthankar Chakraborty headshot

Powell's Hawkish Tone Rattles Wall Street: 5 Ultra-Safe Picks

by Tirthankar Chakraborty

With Powell's hawkish comments flaring up volatility, it is prudent to invest in risk-adjusting stocks like Unitil (UTL), Xcel Energy (XEL), NiSource (NI), Clorox (CLX) & Ingredion (INGR) for steady returns.

Solid Demand to Aid Archer Daniels (ADM) Amid Inflation

by Zacks Equity Research

Archer Daniels (ADM) is likely to continue gaining from healthy demand, strength in the Nutrition unit, portfolio expansion and strategic partnerships. However, inflationary pressure is concerning.

Is Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?

by Zacks Equity Research

Here is how Clorox (CLX) and Coca-Cola FEMSA (KOF) have performed compared to their sector so far this year.

Abhinab Dasgupta headshot

Take the Zacks Approach to Beat the Market: NVIDIA, Block, Clorox in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Abhinab Dasgupta headshot

Take the Zacks Approach to Beat the Market: Ulta Beauty, Clorox, Similarweb in Focus

by Abhinab Dasgupta

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

Clorox (CLX) Q2 Earnings and Sales Beat, Stock Rises 4.2%

by Zacks Equity Research

Clorox's (CLX) Q2 results reflect gains from strong demand trends, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.

Here's What Key Metrics Tell Us About Clorox (CLX) Q2 Earnings

by Zacks Equity Research

The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Clorox (CLX) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of 50.77% and 2.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Factors Likely to Support Clorox's (CLX) Earnings Beat in Q2

by Zacks Equity Research

Clorox's (CLX) Q2 results are likely to reflect gains from strong demand, cost savings, improved productivity and pricing actions. The company's IGNITE strategy also bodes well.

Is Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Here is how Clorox (CLX) and Corteva, Inc. (CTVA) have performed compared to their sector so far this year.

Clorox (CLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

by Zacks Equity Research

Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Colgate (CL) is Well-Poised for Earnings Beat in Q4

by Zacks Equity Research

Colgate's (CL) Q4 results are expected to reflect gains from strong consumer demand, innovation, brand strength, and focus on premiumization and digital transformation.

Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Shaun Pruitt headshot

Time to Buy These Consumer Staples Stocks Before Earnings?

by Shaun Pruitt

As we progress through earnings season, investors may want to pay attention to the Consumer Staples sector as there are quite a few stocks that could beat earnings expectations.

How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Will Colgate's (CL) Growth Strategies Aid Amid Cost Woes?

by Zacks Equity Research

Colgate (CL) is on track with its stringent pricing actions and accelerated revenue growth management plans. Higher raw material and logistic costs continue to hurt.

Here's Why You Should Hold on to Clorox (CLX) Stock Now

by Zacks Equity Research

Despite inflation concerns, Clorox (CLX) looks well poised to drive growth in the future on the back of solid demand, pricing actions, cost savings efforts and other growth strategies.

Clorox (CLX) Up 8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.